Dr. Timothy Hohman is an Associate Professor of Neurology and a cognitive neuroscientist. He received his doctoral degree in neuroscience from American University focusing on cognitive and neural changes during normal aging. He also completed a fellowship as part of the National Institutes of Health Graduate Partnership Program in the Laboratory of Behavioral Neuroscience at the National Institute on Aging. He completed his postdoctoral training at Vanderbilt University in the Center for Human Genetics Research where he applied neuroimaging and neuropsychological measures as quantitative endophenotypes in genetic analyses of Alzheimer’s disease.
As a core faculty member, Dr. Hohman’s research leverages advanced computational approaches from genomics, proteomics, and neuroscience to identify novel markers of Alzheimer’s disease risk and resilience. His interdisciplinary collaborations with the Alzheimer’s Disease Genetics Consortium and others seek to develop new directions in AD research by emphasizing the biology of resilience and highlighting complex genotype-phenotype interactions.
Dr. Hohman was a T32 postdoctoral research fellow as part of the Neurogenomics training program at Vanderbilt University in 2012, a recipient of the Pharmaceutical Research and Manufacturers of America Foundation postdoctoral fellowship in translational medicine and therapeutics in 2013, and a K12 Building Interdisciplinary Research Careers in Women’s Health Scholar in 2015.
Within the VMAC, Dr. Hohman oversees the extensive computational resources of the center and provides key support in the development of neuroimaging, proteomic, and big-data analytical pipelines. Additionally, Dr. Hohman acts as the center’s primary liaison in efforts to leverage publicly available data sources to answer novel research questions.